000 01138 a2200337 4500
005 20250516144547.0
264 0 _c20131125
008 201311s 0 0 eng d
022 _a1523-1747
024 7 _a10.1038/jid.2013.186
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpoendlin, Julia
245 0 0 _aSpironolactone may reduce the risk of incident rosacea.
_h[electronic resource]
260 _bThe Journal of investigative dermatology
_cOct 2013
300 _a2480-2483 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aDatabases, Factual
650 0 4 _aDiuretics
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMale
650 0 4 _aRisk Factors
650 0 4 _aRosacea
_xepidemiology
650 0 4 _aSpironolactone
_xtherapeutic use
700 1 _aVoegel, Johannes J
700 1 _aJick, Susan S
700 1 _aMeier, Christoph R
773 0 _tThe Journal of investigative dermatology
_gvol. 133
_gno. 10
_gp. 2480-2483
856 4 0 _uhttps://doi.org/10.1038/jid.2013.186
_zAvailable from publisher's website
999 _c22677527
_d22677527